Pfizer and BioNTech Have Begun Submitting Data to U.S. Regulators to Seek Emergency Use ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Pfizer and BioNTech have begun submitting data to U.S. regulators to seek emergency use authorization of their COVID-19 vaccine for children under the age of 5, despite weaker-than-expected immune responses in their clinical trial of 2- to 4-year-olds ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)